Corrigendum to “Real-World Effectiveness of Ocrelizumab in Relapsing Multiple Sclerosis: An MSBase Registry Sub-Study” [Multiple Sclerosis and Related Disorders Vol 106
Loading...
Date
2026-05
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier B.V.
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Scopus Q
Source
Multiple Sclerosis and Related Disorders
Volume
109
Issue
Start Page
End Page
